# Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction

Study · id `cardio:ct-nct01580046` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01580046](<https://clinicaltrials.gov/study/NCT01580046>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01580046

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT01580046. Randomized; single masking; primary purpose prevention. Start 2012-04 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT01580046, source copy `cardio:ctgov-nct01580046-2013-10-16`, retrieved 2026-10-26)
- Start date: 2012-04 (registry gives no type) (ClinicalTrials.gov record NCT01580046, source copy `cardio:ctgov-nct01580046-2013-10-16`, retrieved 2026-10-26)
- Primary completion: 2013-12 (anticipated) (ClinicalTrials.gov record NCT01580046, source copy `cardio:ctgov-nct01580046-2013-10-16`, retrieved 2026-10-26)
- Completion: 2013-12 (anticipated) (ClinicalTrials.gov record NCT01580046, source copy `cardio:ctgov-nct01580046-2013-10-16`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01580046, source copy `cardio:ctgov-nct01580046-2013-10-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01580046-2013-10-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Renal Toxicity of Iodixanol and Iopromide in Patients With Renal Dysfunction
- Acronym: RIPE
- Condition: Kidney Failure, Chronic
- Intervention (Drug): iodixanol
- Intervention (Drug): iopromide
- Lead sponsor: Yong Huo
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: 8ef62d5ffb080e36bd4e54ef772b4ea163bc40d4de1f3be8c36491d4c08feeb3
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
